---
title: "Hotgen: The patent for the target of small nucleic acid therapeutic drugs for Alzheimer's disease held by its invested company has been authorized"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253117456.md"
description: "According to Hotgen, recently, a patent titled \"siRNA and its conjugates for inhibiting APP gene expression and applications\" held by its affiliated company Beijing Yaojing Gene Technology Co., Ltd. has officially been authorized. This patent is for a small nucleic acid drug aimed at treating Alzheimer's disease"
datetime: "2025-08-15T00:08:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253117456.md)
  - [en](https://longbridge.com/en/news/253117456.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253117456.md)
generator: "portal-rs"
---

# Hotgen: The patent for the target of small nucleic acid therapeutic drugs for Alzheimer's disease held by its invested company has been authorized

According to Hotgen, recently, a patent for "siRNA and its conjugates that inhibit APP gene expression and their applications" held by Beijing Yaojing Gene Technology Co., Ltd., in which Hotgen has a stake, has officially been authorized. This patent is for a small nucleic acid drug aimed at the treatment of Alzheimer's disease

### Related Stocks

- [688068.CN](https://longbridge.com/en/quote/688068.CN.md)

## Related News & Research

- [RemeGen files board, board committee member list with disclosure responsibilities](https://longbridge.com/en/news/296803857.md)
- [SCR: Record Free Cash Flow and higher earnings in Q2 2026, with stable production and strong outlook](https://longbridge.com/en/news/296821715.md)
- [AFYREN scales bio-based acid output and strengthens climate-resilient positioning](https://longbridge.com/en/news/297214424.md)
- [REG - Luceco PLC - Director/PDMR Shareholding](https://longbridge.com/en/news/296796008.md)
- [Star Energy set for prominent role at REA UK Geothermal Conference 2026](https://longbridge.com/en/news/297160396.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**